Cargando…
Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system
BACKGROUND: Cancer treatment with a variety of chemotherapeutic agents often is associated with delayed adverse neurological consequences. Despite their clinical importance, almost nothing is known about the basis for such effects. It is not even known whether the occurrence of delayed adverse effec...
Autores principales: | Han, Ruolan, Yang, Yin M, Dietrich, Joerg, Luebke, Anne, Mayer-Pröschel, Margot, Noble, Mark |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2397490/ https://www.ncbi.nlm.nih.gov/pubmed/18430259 http://dx.doi.org/10.1186/jbiol69 |
Ejemplares similares
-
CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo
por: Dietrich, Joerg, et al.
Publicado: (2006) -
Identifying the Threshold of Iron Deficiency in the Central Nervous System of the Rat by the Auditory Brainstem Response
por: Greminger, Allison R., et al.
Publicado: (2015) -
Cytokines and Myelination in the Central Nervous System
por: Schmitz, Thomas, et al.
Publicado: (2008) -
The Initial Myelination in the Central Nervous System
por: Yu, Qiang, et al.
Publicado: (2023) -
Cellular Mechanism of Myelination in the Central Nervous System
por: De Robertis, Eduardo, et al.
Publicado: (1958)